157 related articles for article (PubMed ID: 22075484)
1. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
Thomsen M; Nordestgaard BG; Sethi AA; Tybjærg-Hansen A; Dahl M
Eur Respir J; 2012 Mar; 39(3):558-66. PubMed ID: 22075484
[TBL] [Abstract][Full Text] [Related]
2. β2 -adrenergic receptor Thr164IIe polymorphism, blood pressure and ischaemic heart disease in 66 750 individuals.
Thomsen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
J Intern Med; 2012 Mar; 271(3):305-14. PubMed ID: 21883537
[TBL] [Abstract][Full Text] [Related]
3. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
4. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.
Bækvad-Hansen M; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Apr; 37(4):791-9. PubMed ID: 20693256
[TBL] [Abstract][Full Text] [Related]
5. CHRNA3 genotype, nicotine dependence, lung function and disease in the general population.
Kaur-Knudsen D; Nordestgaard BG; Bojesen SE
Eur Respir J; 2012 Dec; 40(6):1538-44. PubMed ID: 22441734
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in scavenger and β₂-adrenergic receptors and risk of pulmonary disease.
Thomsen M
Dan Med J; 2014 Sep; 61(9):B4910. PubMed ID: 25186548
[TBL] [Abstract][Full Text] [Related]
7. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.
Dahl M; Nordestgaard BG; Lange P; Tybjaerg-Hansen A
J Allergy Clin Immunol; 2001 May; 107(5):818-23. PubMed ID: 11344348
[TBL] [Abstract][Full Text] [Related]
8. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.
Rode L; Bojesen SE; Weischer M; Vestbo J; Nordestgaard BG
Thorax; 2013 May; 68(5):429-35. PubMed ID: 23268483
[TBL] [Abstract][Full Text] [Related]
9. Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.
Dahl M; Tybjaerg-Hansen A; Lange P; Nordestgaard BG
Respir Res; 2005 Oct; 6(1):113. PubMed ID: 16212675
[TBL] [Abstract][Full Text] [Related]
10. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
11. A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients.
Yelensky R; Li Y; Lewitzky S; Leroy E; Hurwitz C; Rodman D; Trifilieff A; Paulding CA
Pharmacogenomics J; 2012 Dec; 12(6):484-8. PubMed ID: 22158330
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
14. Two novel mutations in surfactant protein-C, lung function and obstructive lung disease.
Baekvad-Hansen M; Nordestgaard BG; Tybjaerg-Hansen A; Dahl M
Respir Med; 2010 Mar; 104(3):418-25. PubMed ID: 19910179
[TBL] [Abstract][Full Text] [Related]
15. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
16. EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.
Lee J; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Jan; 37(1):18-25. PubMed ID: 20516053
[TBL] [Abstract][Full Text] [Related]
17. β2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals.
Thomsen M; Dahl M; Tybjærg-Hansen A; Nordestgaard BG
J Clin Endocrinol Metab; 2012 Jun; 97(6):E1074-9. PubMed ID: 22466342
[TBL] [Abstract][Full Text] [Related]
18. ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis.
Migita O; Noguchi E; Jian Z; Shibasaki M; Migita T; Ichikawa K; Matsui A; Arinami T
Int Arch Allergy Immunol; 2004 Jun; 134(2):150-7. PubMed ID: 15153795
[TBL] [Abstract][Full Text] [Related]
19. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
[TBL] [Abstract][Full Text] [Related]
20. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
